| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cogent Biosciences, Inc. | Chief Commercial Officer | Common Stock | 216,650 | $8,546,842 | $39.45 | 17 Dec 2025 | Direct |
| Cogent Biosciences, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 65,000 | 17 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | 17 Dec 2025 | 4 | -$3,739,860 | 4 | Chief Commercial Officer | 19 Dec 2025, 16:01 |
| COGT | Cogent Biosciences, Inc. | 23 Jan 2025 | 1 | $0 | 4 | Chief Commercial Officer | 27 Jan 2025, 17:00 |
| COGT | Cogent Biosciences, Inc. | 14 Jan 2025 | 1 | +$332,412 | 4 | Chief Commercial Officer | 15 Jan 2025, 07:00 |
| COGT | Cogent Biosciences, Inc. | 25 May 2024 | 1 | $0 | 4 | Chief Commercial Officer | 29 May 2024, 16:03 |
| COGT | Cogent Biosciences, Inc. | 25 May 2024 | 0 | $0 | 3 | Chief Commercial Officer | 29 May 2024, 16:01 |